Home   Business   Life Science

Subscribe Now

Life Science




Dreamt up over a pint at the Panton Arms: Cambridge chemists tell astonishing story of DNA sequencing after 1m euro prize

Dreamt up over a pint at the Panton Arms: Cambridge chemists tell astonishing story of DNA sequencing after 1m euro prize

Dreamt up over a pint at the Panton Arms: Cambridge chemists tell astonishing story of DNA sequencing after 1m euro prize

Dr Shankar Balasubramanian and Dr David Klenerman also discuss the possibility of $100 genome sequencing.


Unveiled: 30-year vision for Cambridge Biomedical Campus

Unveiled: 30-year vision for Cambridge Biomedical Campus

Unveiled: 30-year vision for Cambridge Biomedical Campus

Homes, shops, restaurants and green space will be integrated alongside hospitals and world-leading life science work.


NeoGenomics to acquire liquid biopsy specialist Inivata in two-stage $415m acquisition

NeoGenomics to acquire liquid biopsy specialist Inivata in two-stage $415m acquisition

NeoGenomics to acquire liquid biopsy specialist Inivata in two-stage $415m acquisition

It will accelerate the roll-out of products.


Meet the 12 Cambridge scientists made fellows of the Royal Society

Meet the 12 Cambridge scientists made fellows of the Royal Society

Meet the 12 Cambridge scientists made fellows of the Royal Society

They were among 63 honoured.

1

Mogrify’s $17m second close will support immuno-oncology and ophthalmology programmes

Mogrify’s $17m second close will support immuno-oncology and ophthalmology programmes

Mogrify’s $17m second close will support immuno-oncology and ophthalmology programmes

The Cambridge Science Park company’s Series A financing has totalled $33m.


‘New era for cancer therapeutics’ opens with acute myeloid leukaemia drug candidate, say Cambridge scientists

‘New era for cancer therapeutics’ opens with acute myeloid leukaemia drug candidate, say Cambridge scientists

‘New era for cancer therapeutics’ opens with acute myeloid leukaemia drug candidate, say Cambridge scientists

STORM Therapeutics aims for clinical trials in 2022.


Phico Therapeutics awarded £13.2m by CARB-X accelerator to fight anti-bacterial resistance

Phico Therapeutics awarded £13.2m by CARB-X accelerator to fight anti-bacterial resistance

Phico Therapeutics awarded £13.2m by CARB-X accelerator to fight anti-bacterial resistance

Its lead product can target bacteria in the lungs without damaging other cells.


Artios Pharma’s DNA damage response collaboration with Novartis worth a potential $1.3bn

Artios Pharma’s DNA damage response collaboration with Novartis worth a potential $1.3bn

Artios Pharma’s DNA damage response collaboration with Novartis worth a potential $1.3bn

It will receive $20m upfront.


Winners of Cambridge Independent Science and Technology Awards revealed

Winners of Cambridge Independent Science and Technology Awards revealed

Winners of Cambridge Independent Science and Technology Awards revealed

Fourteen categories celebrated extraordinary talent, from biotech to AI.


Biofidelity lines up first product after being granted key patent in US protect its cancer diagnosis technology

Biofidelity lines up first product after being granted key patent in US protect its cancer diagnosis technology

Biofidelity lines up first product after being granted key patent in US protect its cancer diagnosis technology

The company has won Start-up of the Year at the Cambridge Independent Science and Technology Awards.


Stage is set for Cambridge Independent Science and Technology Awards

Stage is set for Cambridge Independent Science and Technology Awards

Stage is set for Cambridge Independent Science and Technology Awards

A limited number of tickets are now on sale.


Eliem Therapeutics is out of stealth mode and $80m in the black

Eliem Therapeutics is out of stealth mode and $80m in the black

Eliem Therapeutics is out of stealth mode and $80m in the black

Biotech’s targets include chronic pain, depression, epilepsy and anxiety


Arecor awarded £2.8m to progress insulin product that could enable artificial pancreas system for type I diabetes patients

Arecor awarded £2.8m to progress insulin product that could enable artificial pancreas system for type I diabetes patients

Arecor awarded £2.8m to progress insulin product that could enable artificial pancreas system for type I diabetes patients

CEO Sarah Howell is nominated as CEO of the Year at the Cambridge Independent Science and Technology Awards.


Epigenetics expert Prof Wolf Reik appointed director of the Babraham Institute

Epigenetics expert Prof Wolf Reik appointed director of the Babraham Institute

Epigenetics expert Prof Wolf Reik appointed director of the Babraham Institute

He has been acting director since the death of Prof Michael Wakelam.


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More